在老年人群中与肥胖相关的炎症生物标志物
Georgia Vamvakou1, Nikolaos Theodorakis1, Dimitris Anagnostou1
1Department of Cardiology, Amalia Flemig General Hospital, 15127 Melissia, Greece.
Cells
|November 13, 2025
概括
老年人肥胖,称为脂肪增生,与较高的炎症标志物如C反应性蛋白 (CRP) 有关,增加心血管风险. 这种慢性炎症可能会使老年人肥胖相关的疾病恶化.
科学领域:
- 老年学是一门学科.
- 免疫学 免疫学 免疫学
- 代谢综合征是代谢综合征的一种.
背景情况:
- 老年人的肥胖与慢性低度炎症有关,称为脂肪增生.
- 与正常体重个体相比,超重和肥胖的老年人观察到炎症生物标志物的升高.
研究的目的:
- 研究肥胖和老年人的炎症生物标志物之间的关系.
- 了解肥胖在慢性炎症和相关并发症中的作用.
主要方法:
- 在中年和老年人群中,对与炎症标志物 (CXCL-16,IL-6,阿迪波金,CRP,纤维素原) 相关的人类参数研究的综述.
- 分析不同肥胖类别的炎症标志物水平,以及高血压和糖尿病等并发症的存在.
主要成果:
- 肥胖的老年人表现出明显更高水平的炎症标志物,包括CXCL-16,IL-6,阿迪波金,CRP和纤维素原.
- 这些标志物与肥胖和心血管风险增加的人类测量指标具有积极的相关性.
- 与肥胖相关的并发症,如高血压和糖尿病,进一步加剧了炎症.
结论:
- 老年人肥胖的特点是慢性低度炎症 (肥胖) 的加剧,由高的炎症生物标志物表明.
- 这种炎症状态可能会导致老年人患肥胖相关并发症的发展和进展.
- 进一步研究这些生物标志物在衰老和肥胖中的特定作用,可以为这一群体提供针对性的干预措施.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
525
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
525
Inflammation
61.5K
Overview
61.5K
Drug Dosing: Obese Patients
208
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
208
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
230
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
230


